Yep agree.
Also see my earlier post where I estimated an annualised NPAT to be approx $29m.
Based on that the current PE is roughly 21, which is crazy for a global company growing at such a fast rate.
- Forums
- ASX - By Stock
- BIG
- Ann: December 2017 Quarterly Update & Appendix 4C
Ann: December 2017 Quarterly Update & Appendix 4C, page-35
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online